Header cover image

Telecom Healthcare Sector

Results

2309

0 new

All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.

2,309 companies

Elutia

Market Cap: US$70.3m

A commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation and breast reconstruction in the United States.

ELUT

US$1.72

7D

-17.3%

1Y

-48.0%

TScan Therapeutics

Market Cap: US$70.2m

A clinical-stage biotechnology company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States.

TCRX

US$1.24

7D

-2.4%

1Y

-86.2%

Milestone Scientific

Market Cap: US$70.1m

A biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally.

MLSS

US$0.90

7D

-5.8%

1Y

31.2%

Zura Bio

Market Cap: US$68.7m

A clinical-stage biotechnology company, develops medicines for immune and inflammatory disorders in the United States.

ZURA

US$1.11

7D

-8.3%

1Y

-81.7%

Alto Neuroscience

Market Cap: US$68.5m

Operates as a clinical-stage biopharmaceutical company in the United States.

ANRO

US$2.53

7D

14.0%

1Y

-79.7%

Adlai Nortye

Market Cap: US$68.3m

A clinical-stage biotechnology company, engages in the research and development of pharmaceutical products.

ANL

US$1.85

7D

0%

1Y

-86.0%

Clearside Biomedical

Market Cap: US$67.9m

A biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space.

CLSD

US$0.88

7D

2.3%

1Y

-32.9%

Vitrafy Life Sciences

Market Cap: AU$106.0m

Provides cryopreservation solutions in Australia.

VFY

AU$1.66

7D

-5.1%

1Y

n/a

Austco Healthcare

Market Cap: AU$105.6m

Operates as provider of healthcare communication solutions in Australia, New Zealand, Asia, Europe, and North America.

AHC

AU$0.29

7D

0%

1Y

56.8%

Medicenna Therapeutics

Market Cap: CA$94.2m

An immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases.

MDNA

CA$1.13

7D

6.6%

1Y

-50.2%

Forian

Market Cap: US$67.1m

Provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the life science, healthcare, and financial services industries.

FORA

US$2.15

7D

12.6%

1Y

-19.2%

BeyondSpring

Market Cap: US$66.9m

A clinical stage biopharmaceutical company, focuses on the development of cancer therapies.

BYSI

US$1.66

7D

-1.2%

1Y

-37.9%

Optiscan Imaging

Market Cap: AU$104.4m

Engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Australia, Germany, China, and the United States.

OIL

AU$0.13

7D

8.7%

1Y

13.6%

EDAP TMS

Market Cap: US$65.8m

Develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology in Asia, France, the United States, and internationally.

EDAP

US$1.76

7D

-20.7%

1Y

-73.8%

EDX Medical Group

Market Cap: UK£49.3m

Engages in developing a range of diagnostics testing solutions in the United Kingdom.

EDX

UK£0.15

7D

34.1%

1Y

96.7%

Vita Life Sciences

Market Cap: AU$102.1m

A healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China.

VLS

AU$1.85

7D

-1.9%

1Y

-14.0%

Seres Therapeutics

Market Cap: US$65.1m

A clinical-stage company, focuses on developing biotherapeutics for serious diseases.

MCRB

US$7.46

7D

5.7%

1Y

-59.5%

Kalaris Therapeutics

Market Cap: US$65.1m

A clinical-stage ophthalmology biotech company, engages in developing therapies for the treatment of neovascular retinal diseases.

KLRS

US$3.48

7D

0%

1Y

n/a

Acumen Pharmaceuticals

Market Cap: US$64.8m

A clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer’s disease.

ABOS

US$1.07

7D

9.2%

1Y

-70.7%

MediciNova

Market Cap: US$64.7m

A biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States.

MNOV

US$1.32

7D

-10.2%

1Y

-7.0%

Citius Oncology

Market Cap: US$64.7m

Focuses on the development of novel targeted oncology therapies.

CTOR

US$0.90

7D

6.1%

1Y

-91.9%

IO Biotech

Market Cap: US$64.6m

A clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform.

IOBT

US$0.98

7D

-2.0%

1Y

-29.0%

PDS Biotechnology

Market Cap: US$64.5m

A clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies.

PDSB

US$1.42

7D

18.3%

1Y

-59.3%

Adicet Bio

Market Cap: US$64.3m

A clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States.

ACET

US$0.78

7D

27.4%

1Y

-51.4%

SDI

Market Cap: AU$99.8m

Engages in the research and development, manufacture, and marketing of dental restorative materials, whitening systems, and other dental materials in Australia, Europe, the United States, and Brazil.

SDI

AU$0.84

7D

0%

1Y

1.2%

Context Therapeutics

Market Cap: US$63.9m

A biopharmaceutical company, develops products for the treatment of solid tumors.

CNTX

US$0.71

7D

-8.9%

1Y

-64.4%

Assertio Holdings

Market Cap: US$63.8m

A pharmaceutical company, provides various products to patients in the United States.

ASRT

US$0.67

7D

9.1%

1Y

-37.8%

Exicure

Market Cap: US$63.6m

Does not have significant operations.

XCUR

US$10.06

7D

-12.1%

1Y

306.1%

enVVeno Medical

Market Cap: US$63.5m

A clinical-stage medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease.

NVNO

US$3.62

7D

-0.8%

1Y

-27.5%

Kooth

Market Cap: UK£47.8m

Provides digital mental health services to children, young people, and adults in the United Kingdom.

KOO

UK£1.34

7D

1.1%

1Y

-55.8%

BioSig Technologies

Market Cap: US$63.3m

A medical technology company, provides digital signal processing technology platform services in the United States.

BSGM

US$2.61

7D

34.5%

1Y

58.2%

Jushi Holdings

Market Cap: US$63.1m

A vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for the medical and adult-use markets in the United States.

JUSH.F

US$0.32

7D

-13.4%

1Y

-54.2%

Arovella Therapeutics

Market Cap: AU$98.3m

A biotechnology company, focuses on the development of therapies for the treatment of cancer in Australia and internationally.

ALA

AU$0.083

7D

0%

1Y

-27.8%

Nutriband

Market Cap: US$62.5m

Develops a portfolio of transdermal pharmaceutical products.

NTRB

US$5.62

7D

-1.7%

1Y

25.7%

Medexus Pharmaceuticals

Market Cap: CA$86.8m

Operates as a pharmaceutical company in Canada and the United States.

MDP

CA$2.69

7D

-7.9%

1Y

68.1%

Metagenomi

Market Cap: US$62.1m

A genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States.

MGX

US$1.66

7D

9.9%

1Y

-76.3%

Page 24 of 65